Analyst Ratings For Haemonetics (NYSE:HAE)
Today, JMP Securities reiterated its Outperform rating on Haemonetics (NYSE:HAE) with a price target of $72.00.
Some recent analyst ratings include
- 2/7/2018-JMP Securities Reiterated Rating of Outperform.
- 2/7/2018-Jefferies Group Reiterated Rating of Buy.
- 1/2/2018-Raymond James Financial Upgrade from a “Underperform ” rating to a ” Market Perform” rating.
- 1/2/2018-Morgan Stanley Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
- 11/8/2017-Craig Hallum Reiterated Rating of Hold.
- 11/7/2016-BTIG Research Reiterated Rating of Neutral.
- On 1/2/2018 Mark W Kroll, Director, sold 7,118 with an average share price of $63.00 per share and the total transaction amounting to $448,434.00.
- On 12/1/2017 Pedro P Granadillo, Director, sold 7,118 with an average share price of $57.06 per share and the total transaction amounting to $406,153.08.
- On 11/16/2017 Ronald G Gelbman, Director, sold 5,440 with an average share price of $56.69 per share and the total transaction amounting to $308,393.60.
- On 11/14/2017 Willaim P Burke, CFO, sold 13,193 with an average share price of $54.04 per share and the total transaction amounting to $712,949.72.
- On 11/13/2017 Dan Goldstein, CAO, sold 4,691 with an average share price of $54.93 per share and the total transaction amounting to $257,676.63.
- On 11/10/2017 Susan Bartlett Foote, Director, sold 16,926 with an average share price of $54.19 per share and the total transaction amounting to $917,219.94.
- On 5/22/2017 Ronald Merriman, Director, sold 17,471 with an average share price of $40.33 per share and the total transaction amounting to $704,605.43.
Recent Trading Activity for Haemonetics (NYSE:HAE)
Shares of Haemonetics closed the previous trading session at 68.42 up +2.14 3.23% with shares trading hands.